Charles Schwab’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.33M | Sell |
511,731
-9,685
| -2% | -$82K | ﹤0.01% | 2386 |
|
|
2025
Q1 | $4.19M | Sell |
521,416
-143,671
| -22% | -$1.16M | ﹤0.01% | 2339 |
|
|
2024
Q4 | $5.97M | Sell |
665,087
-78,963
| -11% | -$709K | ﹤0.01% | 2255 |
|
|
2024
Q3 | $5.45M | Buy |
744,050
+89,940
| +14% | +$659K | ﹤0.01% | 2328 |
|
|
2024
Q2 | $3.73M | Buy |
654,110
+115,152
| +21% | +$658K | ﹤0.01% | 2484 |
|
|
2024
Q1 | $2.7M | Buy |
538,958
+100,767
| +23% | +$505K | ﹤0.01% | 2509 |
|
|
2023
Q4 | $3.94M | Buy |
438,191
+52,891
| +14% | +$475K | ﹤0.01% | 2406 |
|
|
2023
Q3 | $2.99M | Buy |
385,300
+73,746
| +24% | +$573K | ﹤0.01% | 2462 |
|
|
2023
Q2 | $3.02M | Buy |
311,554
+5,570
| +2% | +$53.9K | ﹤0.01% | 2422 |
|
|
2023
Q1 | $3.35M | Buy |
305,984
+5,269
| +2% | +$57.7K | ﹤0.01% | 2370 |
|
|
2022
Q4 | $1.3M | Buy |
300,715
+4,414
| +1% | +$19.1K | ﹤0.01% | 2696 |
|
|
2022
Q3 | $2.23M | Buy |
296,301
+100
| +0% | +$752 | ﹤0.01% | 2554 |
|
|
2022
Q2 | $2.98M | Buy |
+296,201
| New | +$2.98M | ﹤0.01% | 2416 |
|